Applied DNA Seeks New York Approval for H5 Bird Flu Test

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Applied DNA Seeks New York Approval for H5 Bird Flu Test

, MT Newswires - 10:42 AM ET 3/26/2025 default

10:42 AM EDT, 03/26/2025 (MT Newswires) -- Applied DNA Sciences ( APDN ) said Wednesday that its Applied DNA Clinical Labs unit submitted a validation package to the New York State Department of Health for the approval of a test for the detection and subtyping on influenza A (H5) virus.

The influenza A (H5) virus, also known as H5 bird flu, is a highly pathogenic avian influenza, or H5N1, the company said.

The firm said its Linea Avian Influenza H5 Dx assay is a multi-target diagnostic assay capable of detecting and discriminating between pan-influenza A and H5 bird flu.

Price: 2.11, Change: +0.01, Percent Change: +0.48

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.